Screener/Healthcare/Biotechnology

ALLO

Allogene Therapeutics, Inc.NASDAQ
$2.20-0.23 (-9.63%)
Small CapPenny StockUnder $5Healthcare
$0.86
$2.80
$2.11
$2.43
EPS (TTM)$-0.75
P/E Ratio—
Dividend Yield—
Market Cap$562.9M
Volume3.56M
Prev Close$2.44
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$41.4M$-0.19——
Q2 '25—-$50.9M———
Q1 '25$0-$59.7M$-0.28——
Q4 '24$0-$59.9M$-0.28——
Q3 '24$0-$66.3M$-0.32——
Q2 '24$0-$66.4M$-0.35——
Q1 '24$22K-$65.0M$-0.38—-295454.5%
Q4 '23$21K-$85.8M$-0.51—-408466.7%
Get Your Daily Market Recap